Asolution Pharmaceuticals Private Limited

Asolution Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24100MH2010PTC202851 Incorporated 07 May 2010 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2024
₹32.73 Cr
▲ 11% YoY
Net loss · FY 2024
₹8.58 Cr
Net margin -26.2%
EBITDA · FY 2024
-₹15.38 Lakh
EBITDA margin -0.5%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.89 Cr
Issued & subscribed
Open charges
₹24.96 Cr
Satisfied ₹37.55 Cr
Company age
16 yrs
Est. 2010
Employees · EPFO
113
Provident fund records

About Asolution Pharmaceuticals Private Limited

Data last updated:

Asolution Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 07 May 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2010PTC202851. Its GSTIN is 27AAICA4492K1Z9 (Maharashtra).

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.89 Cr. It is led by directors Nandkumar Kashinath Chodankar and Laxmi Nandkumar Chodankar.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 11 – A Mittal Chambers Nariman Point, Mumbai, Maharashtra, India – 400021.

As per the financials filed for FY 2024, the company reported a revenue of ₹32.73 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net loss of ₹8.58 Cr (net margin -26.2%) and EBITDA of -₹15.38 Lakh (EBITDA margin -0.5%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 13% over five years.

The company has about 113 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: ASolution Pharmaceuticals. As per MCA filings, the company has open charges of ₹24.96 Cr and satisfied charges of ₹37.55 Cr on record. Court records list 1 case involving the company, including 1 filed against it. The company has 8 deals on record (5 funding rounds, 3 rights issues), with disclosed funding of ₹28.34 Cr; the latest was in March 2017. Its 8 peer companies in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Span Life Sciences Private Limited with revenue of ₹33.08 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 43 overdue payments to 4 micro and small suppliers.

Asolution Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0061988). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website asolution.in.

Company details

CIN U24100MH2010PTC202851
Registration Number 202851
Incorporation Date 07 May 2010
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-33-0061988

Recognitions & Rankings of Asolution Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-33-0061988

Contact details

Asolution Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is asolution.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    11 – A Mittal Chambers Nariman Point, Mumbai, Maharashtra, India – 400021
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Asolution Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Asolution Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Asolution Pharmaceuticals operates one associated brand: ASolution Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Provides API manufacturing, pharmaceutical development, and clinical supply services in India.asolution.in

Business activity

The main business activities of Asolution Pharmaceuticals are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and scientific research and development. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Asolution Pharmaceuticals Private Limited, buy the company report.

Financials of Asolution Pharmaceuticals Private Limited

FY 2024 filings available

Asolution Pharmaceuticals Private Limited reported revenue of ₹32.73 Cr (up 11% YoY) for FY 2024.

Revenue · FY 2024
₹32.73 Cr ▲ 11%
Net loss · FY 2024
₹8.58 Cr margin -26.2%
EBITDA · FY 2024
-₹15.38 Lakh margin -0.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 20%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▼ 147%
3 years · compounded
▲ 37%
5 years · compounded
▲ 34%

Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 11% growth in the latest year. EBITDA fell 147% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹15.38 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹8.58 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-0.5%
Net Profit Margin-26.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Asolution Pharmaceuticals Private Limited, buy the company report.

Board of directors of Asolution Pharmaceuticals Private Limited

Asolution Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Nandkumar Kashinath ChodankarDirector07 May 201016 Years 6 MonthsCurrent
Laxmi Nandkumar ChodankarDirector07 May 201016 Years 6 MonthsCurrent

Peer comparison

Asolution Pharmaceuticals Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Span Life Sciences Private Limited₹33.08 Cr (FY 2025)4.0%Hyderabad, Telangana, India
Orichem Drugs & Pharmaceuticals Pvt. Ltd.₹33.03 Cr (FY 2025)21.0%Indore, Madhya Pradesh, India
Maheshwari Pharmaceuticals (India) Limited₹32.92 Cr (FY 2024)9.0%Delhi, India
Asolution Pharmaceuticals Private Limitedthis company₹32.73 Cr (FY 2024)-₹8.58 Cr-26.2%11.0%113Mumbai, Maharashtra, India
Viruj Chematrix Private Limited₹32.69 Cr (FY 2025)91.0%Hyderabad, Telangana, India
Deccan Nutraceuticals Private Limited₹32.43 Cr (FY 2024)32.0%Pune, Maharashtra, India
Asons Pharmaceuticals Private Limited₹32.4 Cr (FY 2025)43.0%Kalol, Gujarat, India
Sangrose Laboratories Private Limited₹32.28 Cr (FY 2024)34.0%Alappuzha, Kerala, India
Torrvis Pharmaceuticals Private Limited₹31.91 Cr (FY 2025)12.0%Delhi, India

To see the full peer comparison of Asolution Pharmaceuticals Private Limited, buy the company report.

Auditor

Asolution Pharmaceuticals Private Limited is audited by MGB & Co. LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
MGB & Co. LLPFY 2023101169W/W-100035

Shareholding

The shareholding of Asolution Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Asolution Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹24.96 Cr
Satisfied charges
₹37.55 Cr
Breakdown by lending institutions
Others₹24.96 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
18 Aug 2020100367125Others₹3.47 CrOpen
17 Nov 201510604905Others₹21.49 CrOpen
04 Jan 2023100669829Others₹3 CrSatisfied
29 Jan 2022100542544Others₹42.04 LakhSatisfied
06 Jun 2020100357067Others₹60 LakhSatisfied

To see the full charge records of Asolution Pharmaceuticals Private Limited, buy the company report.

Total charge records: 6 View all charges

Deals & funding

Asolution Pharmaceuticals Private Limited has 8 deals on record (5 funding rounds, 3 rights issues), with disclosed funding of ₹28.34 Cr; the latest was in March 2017.

Total deals
8
Funding rounds
5
Rights issues
3
Disclosed funding
₹28.34 Cr

Deals on record (5 of 8)

WhenDealAmountParties
Mar 2017Rights issue₹3.24 CrInvestors: 2 individuals
Mar 2017Rights issue₹3.5 CrInvestors: 3 individuals
Mar 2016Rights issue₹11.96 CrInvestors: 4 individuals
Jun 2013Funding round₹6.47 CrInvestors: 4 individuals
Feb 2011Funding round₹2.99 CrInvestors: 3 individuals

To see the full deal history of Asolution Pharmaceuticals Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Asolution Pharmaceuticals Private Limited was last rated by Icra on 09 Jan 2015.

Rating agencyRated onRating
Icra09 Jan 2015

To see the full credit ratings and regulatory alerts of Asolution Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

Asolution Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 43 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (4 of 4)

SupplierAmount dueDue sinceReported on
Anant Pharmaceuticals Private Limited
Hatch Tech
Omkar Traders
an individual supplier

To see the full MSME payment records of Asolution Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Asolution Pharmaceuticals Private Limited has a workforce of 113 employees on its EPFO records as of Apr 2026, across 1 active EPFO establishment.

Employee count
113
Active EPFO establishments
1
Employee growth
-5%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27113
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19

To see the full employee and EPFO history of Asolution Pharmaceuticals Private Limited, buy the company report.

GST

Asolution Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAICA4492K1Z9MaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Asolution Pharmaceuticals Private Limited, buy the company report.

Recent activity

Asolution Pharmaceuticals Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Laxmi Nandkumar Chodankar was appointed as Director on 07 May 2010.

AGM
Asolution Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Asolution Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge registered on 04 Jan 2023 via Charge ID 100669829 with Others was fully satisfied on 10 Jul 2023.
Charges
A charge registered on 29 Jan 2022 via Charge ID 100542544 with Others was fully satisfied on 10 Jul 2023.
Charges
A charge registered on 28 Aug 2014 via Charge ID 10547757 with Others was fully satisfied on 10 Jul 2023.
Charges
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 100669829 was registered on 04 Jan 2023.
Charges
A charge registered on 06 Jun 2020 via Charge ID 100357067 with Others was fully satisfied on 03 Aug 2022.
Charges
A charge with Others amounted to Rs. 0.42 Cr with Charge ID 100542544 was registered on 29 Jan 2022.
Charges
A charge with Others of Rs. 0.60 Cr registered on 06 Jun 2020 with Charge ID 100357067 was modified on 18 Nov 2020.
Charges
A charge with Others of Rs. 3.47 Cr registered on 18 Aug 2020 with Charge ID 100367125 was modified on 29 Oct 2020.
Charges
A charge with Others amounted to Rs. 3.47 Cr with Charge ID 100367125 was registered on 18 Aug 2020.
Charges
A charge with Others amounted to Rs. 0.60 Cr with Charge ID 100357067 was registered on 06 Jun 2020.

7 earlier events are in the company report.

Frequently asked questions

Asolution Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 07 May 2010 (16+ years old) and is registered under CIN U24100MH2010PTC202851.

Asolution Pharmaceuticals has 2 current directors:

The latest financial statements of Asolution Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Asolution Pharmaceuticals is 27AAICA4492K1Z9, registered in Maharashtra.

The CIN (Corporate Identification Number) of Asolution Pharmaceuticals is U24100MH2010PTC202851. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Asolution Pharmaceuticals has 1 court case on record: 1 filed against it.

Asolution Pharmaceuticals was incorporated on 07 May 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.

Asolution Pharmaceuticals has 8 deals on record (5 funding rounds, 3 rights issues), with disclosed funding of ₹28.34 Cr; the latest was in March 2017.

The peers of Asolution Pharmaceuticals by revenue are Span Life Sciences Private Limited, Orichem Drugs & Pharmaceuticals Pvt. Ltd, Maheshwari Pharmaceuticals (India) Limited, Viruj Chematrix Private Limited, Deccan Nutraceuticals Private Limited and 3 more, all in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Laxmi Nandkumar Chodankar was appointed as Director on 07 May 2010. Nandkumar Kashinath Chodankar was appointed as Director on 07 May 2010.

Yes, Asolution Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-33-0061988).

Asolution Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 43 overdue payments to 4 micro and small suppliers. The latest return was filed on 30 May 2019.